Núria Reig Bolano

Title: Núria Reig Bolano: Innovator in Transthyretin-Associated Amyloidosis Therapy

Introduction

Núria Reig Bolano is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of biotechnology, particularly in the treatment of transthyretin-associated amyloidosis. With a total of 2 patents to his name, his work is paving the way for innovative therapies in this area.

Latest Patents

Núria's latest patents focus on the use of catechol-O-methyltransferase (COMT) inhibitors for the prevention and treatment of transthyretin-associated amyloidosis. His inventions include a method for utilizing these inhibitors in combination therapy with various compounds such as benzoxazole derivatives, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, and epigallocatechin-3-gallate. This innovative approach aims to enhance the efficacy of treatments for this challenging condition.

Career Highlights

Núria Reig Bolano is associated with Som Innovation Biotech, S.L., where he continues to develop groundbreaking therapies. His dedication to research and innovation has positioned him as a key figure in the biotechnology sector.

Collaborations

He collaborates with notable colleagues, including Marc Centellas Casado and Raúl Insa Boronat, to advance research and development in his field.

Conclusion

Núria Reig Bolano's contributions to the treatment of transthyretin-associated amyloidosis through his innovative patents highlight his role as a leading inventor in biotechnology. His work continues to inspire advancements in medical therapies.